| 摘要 |
Disclosed herein is a spiro substituted compound of formula I, wherein the substituents are as defined within the specification, processes for their preparation, pharmaceutical compositions comprising them, and uses in the treatment of disease states associated with angiogenesis, such as cancers associated with protein tyrosine kinases.
|
